IRCT2016041125211N1CompletedPhase 3
Radiologic response rate of chemoradiotherapy in inoperable head and neck squamous cell carcinoma; weekly versus triweekly cisplatin schedule
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 63
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 23 years to 75 years (—)
- Sex
- All
Inclusion Criteria
- •( Pathologic report of Squamous.cell.carcinoma ; Age 18- 70 years ; ECOG performance status of 0-1; No distant metastasis; WBC equal to more than 4000; PLT equal to more than 100000; Hb equal to more than 10; Serum Cr less than 1.5 ; Serum aminotransferase less than twice of normal range.) (Exclusion criteria: Sever medical or psychiatric disorder; Patient who dose not have a good fallow up.)
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 2
FOLFOXIRI With or Without Intensification for Rectal CancerRectal CancerNCT03997435CCTU72
Completed
Phase 2
A phase II study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancerStage III non-small cell lung cancerJPRN-UMIN000010428West Japan Oncology Group44
Completed
Not Applicable
Observational study of FOLFOX therapy for esophageal squamous cell carcinomaJPRN-UMIN000044485Shizuoka Cancer Center93
Not yet recruiting
Phase 1
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24
Recruiting
Phase 1
Phase I study of definitive CRT with paclitaxel, CDDP and 5-FU for clinical stage IA-IIIC esophageal cancer.(PCF-RT)Esophageal cancerJPRN-jRCTs051180082Yamamoto Sachiko24